Medical information Clinical review pending

Genetic Testing

MYH6 Gene Atrial Septal Defect Type 3 Genetic Test

Genetic test to identify mutations in the MYH6 gene associated with Atrial Septal Defect Type 3, a congenital heart condition. Helps understand genetic predisposition and inform management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: No specific fasting is required. Inform the laboratory of any medications you are taking. A clinical history and family history (pedigree chart) are essential for proper test interpretation and should be discussed prior to testing.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the MYH6 Gene Atrial Septal Defect Type 3 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Personal history of Atrial Septal Defect (ASD).
✓Family history of ASD or related heart conditions.
✓Unexplained congenital heart defects.
✓Individuals considering family planning with a family history of heart conditions.
✓Symptoms potentially related to heart conditions (e.g., shortness of breath, fatigue, palpitations).

In plain language

What this test helps you understand

This test helps identify specific genetic mutations in the MYH6 gene associated with Atrial Septal Defect Type 3. It can aid in confirming a diagnosis, understanding the genetic basis of a heart condition, assessing risk for family members, and potentially guiding treatment decisions.

The MYH6 Gene Atrial Septal Defect Type 3 NGS Genetic DNA Test is a specialized genetic analysis designed to detect mutations within the MYH6 gene. This gene provides instructions for making a protein important for the structure and function of heart muscle. Mutations in this gene are linked to certain types of heart conditions, including Atrial Septal Defects (ASDs). ASDs are holes in the wall separating the upper chambers of the heart, which can lead to various cardiovascular issues if not managed properly. This test uses Next Generation Sequencing (NGS) technology for accurate detection of relevant genetic variations. Understanding the genetic basis of ASDs is crucial for early diagnosis, appropriate management, and family planning. This test can provide valuable information for individuals with a personal or family history of heart conditions.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific fasting is required. Inform the laboratory of any medications you are taking. A clinical history and family history (pedigree chart) are essential for proper test interpretation and should be discussed prior to testing.

SampleBlood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.

MethodologyNext Generation Sequencing (NGS) is used to analyze the MYH6 gene for specific mutations.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test specifically analyzes the MYH6 gene for mutations associated with Atrial Septal Defect Type 3. It does not detect mutations in other genes that may cause similar conditions. A negative result does not completely rule out a genetic cause for the condition. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

An ASD is a hole in the wall between the two upper chambers (atria) of the heart. It's a type of congenital heart defect present at birth.

The MYH6 gene provides instructions for making a protein called beta-myosin heavy chain, which is essential for the proper function and contraction of heart muscle.

Individuals with a personal or family history of ASD or related heart conditions may benefit from this test. Discuss with your doctor if it's appropriate for you.

Results indicate the presence or absence of specific mutations in the MYH6 gene. Interpretation often involves a genetic counselor or specialist to discuss the implications for your health and family.

Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.

You can book the test by calling or WhatsApping us at +254711564616. We have locations in Nairobi, Mombasa, and Kisumu, and offer home sample collection.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp